Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Next Generation Sequencing (NGS) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Next Generation Sequencing (NGS) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Targeted Sequencing Whole Exome Sequencing Whole Genome Sequencing Segmented by End User/Segment Academic & Government Research Institutes Pharmaceutical Companies Biotechnology Companies Hospitals & Clinics Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Thermo Fisher Scientific Roche Qiagen PierianDx Perkinelmer Partek Pacific Biosciences of California Oxford Nanopore Technologies New England Biolabs Myriad Genetics Macrogen Illumina Genomatix Gatc Biotech Eurofins Scientific DNASTAR Bio-Rad Laboratories Biomatters Beijing Genomics Institute Agilent Technologies

List of Figures

Figure Next Generation Sequencing (NGS) Picture
Figure Global Next Generation Sequencing (NGS) Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Next Generation Sequencing (NGS) Sales Value CAGR (2020-2027) by Region
Figure Global Next Generation Sequencing (NGS) Sales Value Market Share by Company, 2020
Figure Product Picture of Targeted Sequencing
Figure Product Picture of Whole Exome Sequencing
Figure Product Picture of Whole Genome Sequencing
Figure Global Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure North America Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure Europe Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure Asia Pacific Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure Central & South America Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure Middle East & Africa Next Generation Sequencing (NGS) Sales Value Market Share by Category, 2020
Figure Next Generation Sequencing (NGS) in Academic & Government Research Institutes
Figure Global Next Generation Sequencing (NGS) Market: Academic & Government Research Institutes (2016-2021)
Figure Next Generation Sequencing (NGS) in Pharmaceutical Companies
Figure Global Next Generation Sequencing (NGS) Market: Pharmaceutical Companies (2016-2021)
Figure Next Generation Sequencing (NGS) in Biotechnology Companies
Figure Global Next Generation Sequencing (NGS) Market: Biotechnology Companies (2016-2021)
Figure Next Generation Sequencing (NGS) in Hospitals & Clinics
Figure Global Next Generation Sequencing (NGS) Market: Hospitals & Clinics (2016-2021)
Figure Global Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure North America Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure Europe Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Next Generation Sequencing (NGS) Sales Value Market Share by End User/Segment, 2020
Figure Global Next Generation Sequencing (NGS) Sales Value Market Share by Region (2016-2021)
Figure North America Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Europe Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure North America Next Generation Sequencing (NGS) Sales Value Market Share by Country, 2020
Figure United States Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Canada Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)
Figure Mexico Next Generation Sequencing (NGS) Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Next Generation Sequencing (NGS) Market Status and Forecast (2016-2027) 1.3.2 Global Next Generation Sequencing (NGS) Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Next Generation Sequencing (NGS) Supply by Company 2.1 Global Next Generation Sequencing (NGS) Sales Value by Company 2.2 Next Generation Sequencing (NGS) Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Next Generation Sequencing (NGS) Market Status by Category 3.1 Next Generation Sequencing (NGS) Category Introduction 3.1.1 Targeted Sequencing 3.1.2 Whole Exome Sequencing 3.1.3 Whole Genome Sequencing 3.2 Global Next Generation Sequencing (NGS) Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Next Generation Sequencing (NGS) Market Status by End User/Segment 4.1 Next Generation Sequencing (NGS) Segment by End User/Segment 4.1.1 Academic & Government Research Institutes 4.1.2 Pharmaceutical Companies 4.1.3 Biotechnology Companies 4.1.4 Hospitals & Clinics 4.2 Global Next Generation Sequencing (NGS) Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Next Generation Sequencing (NGS) Market Status by Region 5.1 Global Next Generation Sequencing (NGS) Market by Region 5.2 North America Next Generation Sequencing (NGS) Market Status 5.3 Europe Next Generation Sequencing (NGS) Market Status 5.4 Asia Pacific Next Generation Sequencing (NGS) Market Status 5.5 Central & South America Next Generation Sequencing (NGS) Market Status 5.6 Middle East & Africa Next Generation Sequencing (NGS) Market Status6 North America Next Generation Sequencing (NGS) Market Status 6.1 North America Next Generation Sequencing (NGS) Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Next Generation Sequencing (NGS) Market Status 7.1 Europe Next Generation Sequencing (NGS) Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Next Generation Sequencing (NGS) Market Status 8.1 Asia Pacific Next Generation Sequencing (NGS) Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Next Generation Sequencing (NGS) Market Status 9.1 Central & South America Next Generation Sequencing (NGS) Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Next Generation Sequencing (NGS) Market Status 10.1 Middle East & Africa Next Generation Sequencing (NGS) Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Next Generation Sequencing (NGS) Market Forecast by Category and by End User/Segment 12.1 Global Next Generation Sequencing (NGS) Sales Value Forecast (2022-2027) 12.2 Global Next Generation Sequencing (NGS) Forecast by Category 12.3 Global Next Generation Sequencing (NGS) Forecast by End User/Segment13 Global Next Generation Sequencing (NGS) Market Forecast by Region/Country 13.1 Global Next Generation Sequencing (NGS) Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Thermo Fisher Scientific 14.1.1 Company Information 14.1.2 Next Generation Sequencing (NGS) Product Introduction 14.1.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Roche 14.2.1 Company Information 14.2.2 Next Generation Sequencing (NGS) Product Introduction 14.2.3 Roche Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Qiagen 14.3.1 Company Information 14.3.2 Next Generation Sequencing (NGS) Product Introduction 14.3.3 Qiagen Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 PierianDx 14.4.1 Company Information 14.4.2 Next Generation Sequencing (NGS) Product Introduction 14.4.3 PierianDx Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Perkinelmer 14.5.1 Company Information 14.5.2 Next Generation Sequencing (NGS) Product Introduction 14.5.3 Perkinelmer Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Partek 14.6.1 Company Information 14.6.2 Next Generation Sequencing (NGS) Product Introduction 14.6.3 Partek Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Pacific Biosciences of California 14.7.1 Company Information 14.7.2 Next Generation Sequencing (NGS) Product Introduction 14.7.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Oxford Nanopore Technologies 14.8.1 Company Information 14.8.2 Next Generation Sequencing (NGS) Product Introduction 14.8.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 New England Biolabs 14.9.1 Company Information 14.9.2 Next Generation Sequencing (NGS) Product Introduction 14.9.3 New England Biolabs Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Myriad Genetics 14.10.1 Company Information 14.10.2 Next Generation Sequencing (NGS) Product Introduction 14.10.3 Myriad Genetics Next Generation Sequencing (NGS) Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 Macrogen 14.12 Illumina 14.13 Genomatix 14.14 Gatc Biotech 14.15 Eurofins Scientific 14.16 DNASTAR 14.17 Bio-Rad Laboratories 14.18 Biomatters 14.19 Beijing Genomics Institute 14.20 Agilent Technologies15 Conclusion16 Methodology